HOME >> BIOLOGY >> NEWS
Protein research illustrates how drugs fight malaria, other diseases

s for selective drug action are incomplete," he said.

In the current research, Zhang and Rathod found that parasites are sensitive to drugs that target their DHFR in part because of their inability to rapidly replenish the dead enzyme. Host cells, on the other hand, can rapidly generate excess amounts of the DHFR protein if the drug accidentally enters the host cell. Previously, it was believed the different effects between parasite and host were entirely related to how tightly the drug used against the parasite was bound to the DHFR protein in the parasite.

The latest research offers a new standard for selective targeting, Rathod said. He likens it to the military establishing a battle plan based on good intelligence.

"You can have all the maps, you can have all the guns, you can have all the firepower, but if you don't know where the important targets are, it's a waste. You can do as much harm as good," he said.

The Science paper focuses on malaria, a disease that each year strikes one-seventh of the world's population 900 million people, mostly in southern Asia, sub-Saharan Africa and central and South America and kills 2.7 million people.

However, the same concepts could apply to research into, for example, HIV, cancer, heart disease or Alzheimer's disease, Rathod said. The goal is finding the means to attack certain kinds of cells in ways that aren't toxic to other cells, even cells similar to the ones being attacked.

Malaria is the focus of research in Rathod's lab because it is so widespread and often affects some of the world's poorest populations. In some parts of Africa, for example, many people infected with malaria would be hard pressed to pay even $10 a year for medication, Rathod said. Solving a problem of that magnitude will require scientists, drug manufacturers and social agencies to work together, he said.

"Malaria is a big issue because no vaccines have worked," he said. "Medications have w
'"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
18-Apr-2002


Page: 1 2 3

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... ... 2019 , ... FISO Technologies proudly presents the innovative FOP-M200, ... fiber of 100 microns. With dimensions smaller than any competitive product, FISO is ... leader in the development of fiber optic sensors & signal conditioners used in ...
(Date:5/2/2019)... ... 2019 , ... Philadelphia intellectual property law firm Panitch ... Ph.D., a registered patent agent, has joined the firm as a new member ... technical support and scientific expertise in the pharmaceutical and biotechnical arts and assists ...
(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, the leader in microbial ... Company’s General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately. The ... leave. There will also be an independent investigation into uBiome’s billing practices to ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... ... team that includes a chemical engineer at Worcester Polytechnic Institute (WPI) has developed ... make it possible to manufacture isobutanol and other biofuels more economically. , Isobutanol, ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/8/2019)... ... April 08, 2019 , ... ... solutions, announced today the launch of their app integration solution, CT Cloud Unite. ... and contact-orientated applications while using CT Cloud Voice and Skype for Business solutions. ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific ... CARB-X has proceeded with a second stage of funding for Specific’s Reveal™ rapid ... is on top of the $1.7 million already awarded by CARB-X. The additional ...
Breaking Biology Technology:
Cached News: